rs16856462

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_052934.4(SLC26A9):​c.2243A>G​(p.His748Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0788 in 1,612,986 control chromosomes in the GnomAD database, including 5,749 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.099 ( 920 hom., cov: 33)
Exomes 𝑓: 0.077 ( 4829 hom. )

Consequence

SLC26A9
NM_052934.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.93

Publications

21 publications found
Variant links:
Genes affected
SLC26A9 (HGNC:14469): (solute carrier family 26 member 9) This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures yet have markedly different tissue expression patterns. The product of this gene is a highly selective chloride ion channel regulated by WNK kinases. Alternative splicing results in multiple transcript variants encoding differing isoforms.[provided by RefSeq, Dec 2008]
SLC26A9 Gene-Disease associations (from GenCC):
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014667511).
BP6
Variant 1-205918853-T-C is Benign according to our data. Variant chr1-205918853-T-C is described in ClinVar as Benign. ClinVar VariationId is 403452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC26A9NM_052934.4 linkc.2243A>G p.His748Arg missense_variant Exon 19 of 21 ENST00000367135.8 NP_443166.1
SLC26A9NM_134325.3 linkc.2243A>G p.His748Arg missense_variant Exon 19 of 22 NP_599152.2
SLC26A9XM_011509121.3 linkc.1976A>G p.His659Arg missense_variant Exon 18 of 20 XP_011507423.1
SLC26A9XM_011509122.3 linkc.1751A>G p.His584Arg missense_variant Exon 16 of 18 XP_011507424.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC26A9ENST00000367135.8 linkc.2243A>G p.His748Arg missense_variant Exon 19 of 21 1 NM_052934.4 ENSP00000356103.3
SLC26A9ENST00000340781.8 linkc.2243A>G p.His748Arg missense_variant Exon 18 of 21 1 ENSP00000341682.4
SLC26A9ENST00000367134.2 linkc.2243A>G p.His748Arg missense_variant Exon 19 of 22 5 ENSP00000356102.2
SLC26A9ENST00000491127.5 linkn.1627A>G non_coding_transcript_exon_variant Exon 11 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.0989
AC:
15044
AN:
152108
Hom.:
916
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.169
Gnomad AMI
AF:
0.101
Gnomad AMR
AF:
0.0753
Gnomad ASJ
AF:
0.136
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0325
Gnomad FIN
AF:
0.0430
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0803
Gnomad OTH
AF:
0.115
GnomAD2 exomes
AF:
0.0718
AC:
18044
AN:
251402
AF XY:
0.0700
show subpopulations
Gnomad AFR exome
AF:
0.177
Gnomad AMR exome
AF:
0.0502
Gnomad ASJ exome
AF:
0.133
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0467
Gnomad NFE exome
AF:
0.0839
Gnomad OTH exome
AF:
0.0859
GnomAD4 exome
AF:
0.0767
AC:
111996
AN:
1460760
Hom.:
4829
Cov.:
31
AF XY:
0.0758
AC XY:
55073
AN XY:
726544
show subpopulations
African (AFR)
AF:
0.174
AC:
5826
AN:
33464
American (AMR)
AF:
0.0527
AC:
2358
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3463
AN:
26106
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39674
South Asian (SAS)
AF:
0.0325
AC:
2799
AN:
86200
European-Finnish (FIN)
AF:
0.0478
AC:
2549
AN:
53378
Middle Eastern (MID)
AF:
0.148
AC:
852
AN:
5754
European-Non Finnish (NFE)
AF:
0.0802
AC:
89149
AN:
1111140
Other (OTH)
AF:
0.0828
AC:
4994
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5724
11447
17171
22894
28618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3252
6504
9756
13008
16260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0990
AC:
15067
AN:
152226
Hom.:
920
Cov.:
33
AF XY:
0.0946
AC XY:
7039
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.169
AC:
7003
AN:
41512
American (AMR)
AF:
0.0751
AC:
1148
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
473
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.0323
AC:
156
AN:
4830
European-Finnish (FIN)
AF:
0.0430
AC:
457
AN:
10618
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0803
AC:
5461
AN:
68000
Other (OTH)
AF:
0.114
AC:
241
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
698
1396
2094
2792
3490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0911
Hom.:
2314
Bravo
AF:
0.106
TwinsUK
AF:
0.0806
AC:
299
ALSPAC
AF:
0.0781
AC:
301
ESP6500AA
AF:
0.168
AC:
740
ESP6500EA
AF:
0.0840
AC:
722
ExAC
AF:
0.0742
AC:
9010
Asia WGS
AF:
0.0220
AC:
76
AN:
3478
EpiCase
AF:
0.0930
EpiControl
AF:
0.0937

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.0010
DANN
Benign
0.25
DEOGEN2
Benign
0.032
.;T;.
Eigen
Benign
-2.4
Eigen_PC
Benign
-2.5
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.33
.;T;T
MetaRNN
Benign
0.0015
T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
0.20
N;N;N
PhyloP100
-2.9
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.11
N;N;N
REVEL
Benign
0.26
Sift
Benign
0.66
T;T;T
Sift4G
Benign
0.92
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.011
MPC
0.17
ClinPred
0.0041
T
GERP RS
-10
Varity_R
0.021
gMVP
0.18
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16856462; hg19: chr1-205887981; COSMIC: COSV61605864; COSMIC: COSV61605864; API